PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 11, 2022American Journal of Hypertension99 citations

Thiazide and the Thiazide-Like Diuretics: Review of Hydrochlorothiazide, Chlorthalidone, and Indapamide

View Full Paper
MEMichael E. ErnstPreventive CardiologyMFMichelle A. FravelUniversity of Iowa

Key Result

Thiazide and thiazide-like diuretics remain effective first-line agents for lowering cardiovascular events, yet only about one-third of hypertensive patients currently receive them.

Structured PICO

P
Population
Hypertensive patients
I
Intervention
Thiazide and thiazide-like diuretics (hydrochlorothiazide, chlorthalidone, and indapamide)
O
Outcome
Blood pressure reduction and cardiovascular events

Thiazide and thiazide-like diuretics remain an indispensable, though underutilized, component of antihypertensive regimens for achieving adequate blood pressure control and lowering cardiovascular events.

Limitations

  • Lack of availability in convenient formulations for thiazide-like agents
  • Few head-to-head comparisons within the class

Abstract

The term thiazide is universally understood to refer to diuretics that exert their principal action in the distal tubule. The thiazide class is heterogenous and can be further subdivided into compounds containing the benzothiadiazine ring structure-the thiazide-type (e.g., hydrochlorothiazide)-and those lacking the benzothiadiazine ring-the thiazide-like (e.g., chlorthalidone and indapamide) drugs. Thiazide-like agents are longer acting and constitute the diuretics used in most of the cardiovascular outcome trials that established benefits of treatment with diuretics, but pragmatic aspects, such as lack of availability in convenient formulations, limit their use. Regardless of class heterogeneity, thiazides have retained importance in the management of hypertension for over 60 years. They are reliably effective as monotherapy in a majority of hypertensive patients, and augment the efficacy of other classes of antihypertensives when used in combination. Importantly, a thiazide-based treatment regimen lowers cardiovascular events, and their sturdy effect reinforces their place among the recommended first-line agents to treat hypertension in major domestic and international hypertension guidelines. There are few head-to-head comparisons within the class, but potential differences have been explored indirectly as well as in non-blood pressure mechanisms and potential pleiotropic properties. Until proven otherwise, the importance of these differences remains speculative, and clinicians should assume that cardiovascular events will be lowered similarly across agents when equivalent blood pressure reduction occurs. Thiazides remain underutilized, with only about one-third of hypertensive patients receiving them. For many patients, however, a thiazide is an indispensable component of their regimen to achieve adequate blood pressure control.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ernst et al. (2022) conducted a review in Hypertension. Thiazide and thiazide-like diuretics was evaluated. Thiazide and thiazide-like diuretics remain effective first-line agents for lowering cardiovascular events, yet only about one-third of hypertensive patients currently receive them.

synapsesocial.com/papers/6a129c73ea48cb855a352ceahttps://doi.org/10.1093/ajh/hpac048
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial.1990 · 219 citations
  2. 2Use of Diuretics in Patients with Hypertension2009 · 232 citations
  3. 3Hydrochlorothiazide Versus Chlorthalidone2003 · 317 citations
  4. 4A review of the prescribing trend of thiazide‐type and thiazide‐like diuretics in hypertension: A UK perspective2019 · 31 citations
  5. 5Thiazide-Like Diuretics Attenuate Agonist-Induced Vasoconstriction by Calcium Desensitization Linked to Rho Kinase2004 · 62 citations